Alnylam shares take a hit amid sluggish sales of first drug
November 07, 2018 at 11:33 AM EST
The drug, Onpattro, treats a rare disease that is difficult to diagnose, which poses a challenge for Alnylam in building a patient base.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|